학술논문

The CAR‐HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL.
Document Type
Article
Source
American Journal of Hematology; Nov2023, Vol. 98 Issue 11, p1699-1710, 12p
Subject
Language
ISSN
03618609